Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC UC-112 | 383392-66-3 | 98.9% | 10 MG
Supplier: Medchemexpress LLC HY1284210MG
UC-112 is a survivin and XIAP modulator that exhibits anticancer activity. It selectively downregulates and degrades survivin through the ubiquitin-mediated proteasomal degradation pathway and also reduces XIAP levels in in vivo tumor models. UC-112 activates caspase-3/7 and caspase-9, leading to cancer cell apoptosis. It is suitable for studies related to melanoma, prostate cancer, and other cancer research.
- Selectively downregulates and degrades survivin via the ubiquitin-mediated proteasomal degradation pathway.
- Reduces XIAP levels in in vivo tumor models.
- Activates caspase-3/7 and caspase-9, inducing cancer cell apoptosis.
- Applicable to studies on melanoma, prostate cancer, and cancer-related research.
- Potently inhibits proliferation of A375, M14, PC-3, and DU145 cancer cells.
- Alters cell cycle distribution of A375 melanoma cells.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?